GALT
Galectin Therapeutics Inc.
$5.81
+$0.74(+14.60%)
53
Overall
40
Value
66
Tech
--
Quality
Market Cap
$307.49M
Volume
461.08K
52W Range
$0.73 - $6.55
Target Price
$6.00
Key Metrics Overview
| Market Cap | $307.49M | P/E Ratio | N/A |
| 52W High | $6.55 | 52W Low | $0.73 |
| Div Yield | N/A | Payout Ratio | N/A |
| EPS Growth 3Y | N/A | 52W Position | 87.3% |
| Overall Score | 53 | Value Score | 40 |
| Quality Score | -- | Technical Score | 66 |
Growth Analysis
| EPS Current Est | $-0.49 | EPS Next Est | $-0.44 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
No data available
EBITDA (5Y)
No data available
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | GALT | $5.81 | +14.6% | 461.08K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Galectin Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW